The global animal health market size is expected to reach USD 112.36 billion by 2030, expanding at 8.8% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increased investments in animal health R&D, increased diagnostic rates, initiatives by key companies, and increased animal health expenditure. The market has also remained largely resilient during the COVID-19 pandemic.
The market especially for the companion animal segment was positively impacted during late 2020 and 2021, due to increased pet adoption rates, pet humanization trends, and improved overall diagnostics business sales with increased awareness among pet parents. During 2022 and 2023 however, macroeconomic uncertainties, such as global recession and inflation, are expected to impact market revenues for a short period.
The emergence of veterinary health information systems, specifically in developed economies, is expected to provide high growth potential in the future. With the help of these systems, data generated in veterinary clinics can be uploaded on the internet, which can be further shared with other researchers and clinicians. The incorporation of this technology will facilitate real-time analysis for fluctuations in disease prevalence. As a consequence of the aforementioned factors, it is presumed that there will be a significant improvement in the overall penetration rate of veterinary health products, which is anticipated to fuel market demand as well as revenue.
The threat of zoonotic infections spreading through ticks, and fleas or through contact with animals is high. The WHO is involved in various cross-sectoral activities for the purpose of addressing health threats at the human-animal-ecosystem interface. Food-borne zoonoses, antimicrobial resistance, and emerging zoonoses are some of the threats in the animal health market. Also, MediLabSecure, a laboratory network project, was initiated with an aim of identifying emerging viruses and pathogens in 19 countries in the Mediterranean region. The implementation of a wide range of technologies for the detection and monitoring of various animal diseases is one of the major growth contributing factors.
North America captured a substantial share of the global market, owing to a wide range of definitive measures adopted by welfare organizations, technological advancements, rising incidence of zoonotic diseases, and an increasing number of pet owners. Asia Pacific is expected to exhibit lucrative growth over the coming years as a consequence of consistent R&D investments deployed by prominent players and their efforts to commercialize branded and generic therapeutics at a relatively inexpensive price.
Key market participants employ various strategies, such as expanding their product portfolio, to gain a competitive advantage. For instance, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for the protection of poultry against Infectious Bursal Disease (IBD). This added to Zoetis’ product portfolio of recombinant vector vaccines.
Request a free sample copy or view report summary: Animal Health Market Report
By product, pharmaceuticals dominated the market with a share of over 40% in 2022, due to a significant increase in the adoption of pets, which demands long-term health plans
Based on animal type, the companion animal segment is anticipated to grow at a lucrative rate of 9% during the forecast period, owing to an increased need for companionship, increasing pet expenditure, and adoption of pet insurance
By distribution channel, retail channels, and e-commerce platforms accounted for a notable share owing to factors such as convenience associated with online pharmacies and the increasing number of retail pharmacies
In terms of end-use, the Point-of-care testing/in-house testing segment is expected to grow at the fastest CAGR of about 13% during the forecast period, due to an increase in demand for related products and services
In 2022, North America accounted for the largest share of over 30% of the global animal health industry owing to the presence of established pharmaceutical companies consistently striving for extensive commercialization of their products
Asia Pacific is anticipated to grow at a rate of about 10% during the forecast period, owing to the high clinical urgency to curb the incidence of zoonotic diseases and management of disease outbreaks, such as swine influenza
Industry rivalry in the market is expected to remain at a higher level over the forecast period. Market players are involved in adopting extensive growth strategies such as entering strategic alliances, engaging in product differentiation, and expansion of product portfolio in an attempt to capture a larger share of the market
In February 2021, Ceva and INRAE signed an agreement to collaborate in the arena of animal health. This partnership is expected to accelerate innovation and the development of new products
Grand View Research has segmented the global animal health market based on animal type, product, distribution channel, end-use, and region:
Animal Health Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Sheep & Goats
Animal Health Product Outlook (Revenue, USD Million, 2018 - 2030)
Attenuated Live Vaccines
Other Vaccines & Biologics
Medicinal Feed Additives
Consumables, reagents and kits
Instruments and devices
Equipment & Disposables
Critical Care Consumables
Fluid Management Equipment
Temperature Management Equipment
Rescue & Resuscitation Equipment
Patient Monitoring Equipment
Animal Health Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Hospital/ Clinic Pharmacy
Animal Health End-use Outlook (Revenue, USD Million, 2018 - 2030)
Veterinary Reference Laboratories
Point-of-care Testing/In-house Testing
Veterinary Hospitals & Clinics
Animal Health Regional Outlook (Revenue, USD Million, 2018 - 2030)
Rest of Europe
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of MEA
List of Key Players in the Animal Health Market
Ceva Santé Animale
Merck & Co., Inc.
Boehringer Ingelheim GmbH
Dechra Pharmaceuticals plc
IDEXX Laboratories, Inc.
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
"The quality of research they have done for us has been excellent..."